CSTL insider trading — Castle Biosciences Inc
Over the last 90 days, insiders at Castle Biosciences Inc (CSTL) made 0 open-market purchases worth $0 and 3 open-market sales worth $1.58M, making them net sellers by $1.58M. The largest sale was by Stokes Frank (Chief Financial Officer), who sold 24,908 shares for $742K on Aug 14, 2026.
Updated Oct 16, 2026.
Recent CSTL insider transactions
Every Form 4 filed by Castle Biosciences Inc officers, directors and 10% owners in the last 90 days, newest first. P = open-market purchase, S = open-market sale; other codes are awards, option exercises, tax withholding or gifts.
| Trade date | Insider | Role | Type | Ownership | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|---|
| Oct 12, 2026 | Juvenal Tobin W | Chief Commercial Officer | S · Sale · 10b5-1 | Direct | 3,288 | $33.64 | $111K | Form 4 |
| Oct 5, 2026 | Maetzold Derek J | Pres. & Chief Exec. Officer | M · Option exercise · 10b5-1 | Direct | 8,165 | $2.39 | $20K | Form 4 |
| Oct 5, 2026 | Maetzold Derek J | Pres. & Chief Exec. Officer | S · Sale · 10b5-1 | Direct | 8,580 | $35.57 | $305K | Form 4 |
| Oct 5, 2026 | Maetzold Derek J | Pres. & Chief Exec. Officer | S · Sale · 10b5-1 | Indirect | 5,916 | $35.57 | $210K | Form 4 |
| Oct 1, 2026 | Oelschlager Kristen M | Chief Operating Officer | M · Option exercise · 10b5-1 | Direct | 4,153 | $3.38 | $14K | Form 4 |
| Oct 1, 2026 | Oelschlager Kristen M | Chief Operating Officer | S · Sale · 10b5-1 | Direct | 4,153 | $35.95 | $149K | Form 4 |
| Sep 30, 2026 | Juvenal Tobin W | Chief Commercial Officer | S · Sale · 10b5-1 | Direct | 1,034 | $34.20 | $35K | Form 4 |
| Sep 29, 2026 | Juvenal Tobin W | Chief Commercial Officer | S · Sale · 10b5-1 | Direct | 5,543 | $35.50 | $197K | Form 4 |
| Sep 21, 2026 | Maetzold Derek J | Pres. & Chief Exec. Officer | M · Option exercise · 10b5-1 | Direct | 8,580 | $2.39 | $21K | Form 4 |
| Sep 21, 2026 | Maetzold Derek J | Pres. & Chief Exec. Officer | S · Sale · 10b5-1 | Direct | 8,580 | $35.33 | $303K | Form 4 |
| Sep 21, 2026 | Maetzold Derek J | Pres. & Chief Exec. Officer | S · Sale · 10b5-1 | Indirect | 5,916 | $35.33 | $209K | Form 4 |
| Sep 15, 2026 | Juvenal Tobin W | Chief Commercial Officer | S · Sale · 10b5-1 | Direct | 3,294 | $35.14 | $116K | Form 4 |
| Sep 14, 2026 | Juvenal Tobin W | Chief Commercial Officer | S · Sale · 10b5-1 | Direct | 3,306 | $32.32 | $107K | Form 4 |
| Sep 11, 2026 | Maetzold Derek J | Pres. & Chief Exec. Officer | M · Option exercise · 10b5-1 | Direct | 8,584 | $2.39 | $21K | Form 4 |
| Sep 11, 2026 | Maetzold Derek J | Pres. & Chief Exec. Officer | S · Sale · 10b5-1 | Direct | 8,584 | $32.02 | $275K | Form 4 |
| Sep 11, 2026 | Maetzold Derek J | Pres. & Chief Exec. Officer | S · Sale · 10b5-1 | Indirect | 5,934 | $32.02 | $190K | Form 4 |
| Sep 1, 2026 | Oelschlager Kristen M | Chief Operating Officer | M · Option exercise · 10b5-1 | Direct | 4,152 | $3.38 | $14K | Form 4 |
| Sep 1, 2026 | Oelschlager Kristen M | Chief Operating Officer | S · Sale · 10b5-1 | Direct | 4,152 | $33.39 | $139K | Form 4 |
| Aug 31, 2026 | Juvenal Tobin W | Chief Commercial Officer | S · Sale · 10b5-1 | Direct | 1,730 | $32.81 | $57K | Form 4 |
| Aug 28, 2026 | Maetzold Derek J | Pres. & Chief Exec. Officer | M · Option exercise · 10b5-1 | Direct | 12,428 | $2.39 | $30K | Form 4 |
| Aug 28, 2026 | Maetzold Derek J | Pres. & Chief Exec. Officer | S · Sale · 10b5-1 | Direct | 12,428 | $33.20 | $413K | Form 4 |
| Aug 28, 2026 | Maetzold Derek J | Pres. & Chief Exec. Officer | S · Sale · 10b5-1 | Indirect | 6,132 | $33.20 | $204K | Form 4 |
| Aug 25, 2026 | Juvenal Tobin W | Chief Commercial Officer | S · Sale · 10b5-1 | Direct | 9,050 | $35.04 | $317K | Form 4 |
| Aug 25, 2026 | Oelschlager Kristen M | Chief Operating Officer | S · Sale | Indirect | 12,384 | $34.42 | $426K | Form 4 |
| Aug 24, 2026 | Oelschlager Kristen M | Chief Operating Officer | S · Sale | Indirect | 12,218 | $33.69 | $412K | Form 4 |
| Aug 17, 2026 | Juvenal Tobin W | Chief Commercial Officer | S · Sale · 10b5-1 | Direct | 1,730 | $29.59 | $51K | Form 4 |
| Aug 14, 2026 | Stokes Frank | Chief Financial Officer | S · Sale | Direct | 24,908 | $29.77 | $742K | Form 4 |
| Aug 14, 2026 | Maetzold Derek J | Pres. & Chief Exec. Officer | M · Option exercise · 10b5-1 | Direct | 1,100 | $2.39 | $3K | Form 4 |
| Aug 14, 2026 | Maetzold Derek J | Pres. & Chief Exec. Officer | S · Sale · 10b5-1 | Direct | 1,100 | $30.02 | $33K | Form 4 |
| Aug 14, 2026 | Maetzold Derek J | Pres. & Chief Exec. Officer | S · Sale · 10b5-1 | Indirect | 6,132 | $30.02 | $184K | Form 4 |
| Aug 5, 2026 | Maetzold Derek J | Pres. & Chief Exec. Officer | M · Option exercise · 10b5-1 | Direct | 2,546 | $2.39 | $6K | Form 4 |
| Aug 5, 2026 | Maetzold Derek J | Pres. & Chief Exec. Officer | S · Sale · 10b5-1 | Direct | 2,546 | $30.68 | $78K | Form 4 |
| Aug 5, 2026 | Maetzold Derek J | Pres. & Chief Exec. Officer | S · Sale · 10b5-1 | Indirect | 1,029 | $30.68 | $32K | Form 4 |
| Aug 4, 2026 | Maetzold Derek J | Pres. & Chief Exec. Officer | M · Option exercise · 10b5-1 | Direct | 20,356 | $2.39 | $49K | Form 4 |
| Aug 4, 2026 | Maetzold Derek J | Pres. & Chief Exec. Officer | S · Sale · 10b5-1 | Direct | 20,356 | $31.11 | $633K | Form 4 |
| Aug 4, 2026 | Maetzold Derek J | Pres. & Chief Exec. Officer | S · Sale · 10b5-1 | Indirect | 15,085 | $31.11 | $469K | Form 4 |
| Nov 24, 2025 | Juvenal Tobin W | Chief Commercial Officer | S · Sale · 10b5-1 | Direct | 1,301 | $38.39 | $50K | Form 4 |
| Aug 3, 2026 | Oelschlager Kristen M | Chief Operating Officer | S · Sale · 10b5-1 | Direct | 8,586 | $29.77 | $256K | Form 4 |
| Aug 3, 2026 | Juvenal Tobin W | Chief Commercial Officer | S · Sale · 10b5-1 | Direct | 1,730 | $28.25 | $49K | Form 4 |
| Jul 31, 2026 | Juvenal Tobin W | Chief Commercial Officer | S · Sale · 10b5-1 | Direct | 17,310 | $29.31 | $507K | Form 4 |
| Aug 3, 2026 | Maetzold Derek J | Pres. & Chief Exec. Officer | M · Option exercise · 10b5-1 | Direct | 10,664 | $2.39 | $25K | Form 4 |
| Aug 3, 2026 | Maetzold Derek J | Pres. & Chief Exec. Officer | S · Sale · 10b5-1 | Direct | 10,664 | $30.35 | $324K | Form 4 |
| Aug 3, 2026 | Maetzold Derek J | Pres. & Chief Exec. Officer | S · Sale · 10b5-1 | Indirect | 7,829 | $30.35 | $238K | Form 4 |
| Jul 31, 2026 | Maetzold Derek J | Pres. & Chief Exec. Officer | M · Option exercise · 10b5-1 | Direct | 6,480 | $2.39 | $15K | Form 4 |
| Jul 31, 2026 | Maetzold Derek J | Pres. & Chief Exec. Officer | S · Sale · 10b5-1 | Direct | 6,480 | $30.15 | $195K | Form 4 |
| Jul 31, 2026 | Maetzold Derek J | Pres. & Chief Exec. Officer | S · Sale · 10b5-1 | Indirect | 3,673 | $30.15 | $111K | Form 4 |
| Jul 27, 2026 | Maetzold Derek J | Pres. & Chief Exec. Officer | M · Option exercise · 10b5-1 | Direct | 6,214 | $2.39 | $15K | Form 4 |
| Jul 27, 2026 | Maetzold Derek J | Pres. & Chief Exec. Officer | S · Sale · 10b5-1 | Direct | 6,214 | $24.16 | $150K | Form 4 |
| Jul 27, 2026 | Maetzold Derek J | Pres. & Chief Exec. Officer | S · Sale · 10b5-1 | Indirect | 3,622 | $24.16 | $88K | Form 4 |
CSTL insider trading FAQ
Are insiders buying CSTL stock?
Not on the open market. In the last 90 days, Castle Biosciences Inc insiders made no open-market purchases, and 3 open-market sales totaling $1.58M. Purchases with the insider's own money are generally seen as a stronger signal than sales, which happen for many reasons (taxes, diversification, planned 10b5-1 sales).
Who are the insiders trading CSTL?
Recent sellers: Oelschlager Kristen M, Stokes Frank.
Where does CSTL insider trading data come from?
Every transaction comes from SEC Form 4 filings on EDGAR. Company officers, directors and 10% owners must file a Form 4 within two business days of buying or selling. InsiderBolt reads these filings directly from the SEC.
More stocks with insider activity
Insider trading data is for informational purposes only and is not investment advice. Filings can be amended; always confirm details on SEC EDGAR.